Premature birth is a significant global problem and the leading cause of newborn deaths. Tobacco smoking has been associated with premature birth for over 50 years. The mechanisms through which smoking exerts its effects on pregnancy outcomes remain unclear. In this review, we discuss rates of prematurity and smoking in pregnancy, the evidence of a causal relationship between tobacco and preterm birth, and proposed biochemical pathways through which the interaction is mediated. The suggested mechanisms include nicotine-induced vasoconstriction, carbon monoxide–induced fetal hypoxia, cadmium disruption of calcium signaling, altered steroid hormone production, disruption of prostaglandin synthesis, and changed responses to oxytocin. The relative importance of each of these pathways is yet to be ascertained. Further research is necessary to explore the mechanisms through which smoking exerts its effect on gestational length and the process of parturition. Moreover, the risks of nicotine replacement in pregnancy should be investigated further.
BlencoweHCousensSOestergaardMZ. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379
(9832):2162–2172.
2.
HowsonCP KMLawnJE, eds. March of Dimes, PMNCH, Save the Children, WHO. Born to Soon: The Global Action Report on Preterm Birth. Geneva: World Health Organization; 2012.
3.
SimpsonWJLindaL. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol. 1957;73
(4):807–815.
4.
GoldenbergRLCulhaneJFIamsJDRomeroR. Epidemiology and causes of preterm birth. Lancet. 2008;371
(9606):75–84.
5.
BerkowitzGSPapiernikE. Epidemiology of preterm birth. Epidemiol Rev. 1993;15
(2):414–443.
6.
LorenzJMWoolieverDEJettonJRPanethN. A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med. 1998;152
(5):425–435.
7.
HendersonJJ MONewnhamJPPennellCE. Preterm birth aetiology 2004–2008. Maternal factors associated with three phenotypes: spontaneous preterm labour, preterm pre-labour rupture of membranes and medically indicated preterm birth. J Matern Fetal Neonatal Med. 2012;25
(6):642–647.
8.
GoldenbergRLHauthJCAndrewsWW. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342
(20):1500–1507.
9.
RomeroREspinozaJKusanovicJP. The preterm parturition syndrome. BJOG. 2006;113
(suppl 3):17–42.
10.
SmithLKDraperESManktelowBNDorlingJSFieldDJ. Socioeconomic inequalities in very preterm birth rates. Arch Dis Child Fetal Neonatal Ed. 2007;92
(1):F11–F14.
11.
Kyrklund-BlombergNBCnattingiusS. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol. 1998;179
(4):1051–1055.
12.
CastlesAAdamsEKMelvinCLKelschCBoultonML. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med. 1999;16
(3):208–215.
13.
CnattingiusS. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res. 2004;6
(suppl 2):S125–S140.
14.
World Health Organisation. Report on the Global Tobacco Epidemic - the MPOWER Package. Geneva: World Health Organisation; 2008.
15.
SalihuHMWilsonRE. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev. 2007;83
(11):713–720.
16.
LambersDSClarkKE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996;20
(2):115–126.
17.
ChanBEinarsonAKorenG. Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis. 2005;24
(2):19–23.
18.
BeenJVNurmatovUBCoxBNawrotTSvan SchayckCPSheikhA. Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet. 2014;383
(9928):1549–1560.
19.
MackayDFNelsonSMHawSJPellJP. Impact of Scotland’s smoke-free legislation on pregnancy complications: retrospective cohort study. PLoS Med. 2012;9(3): e1001175.
20.
PageRLIISlejkoJFLibbyAM. A citywide smoking ban reduced maternal smoking and risk for preterm births: a Colorado natural experiment. J Womens Health (Larchmt). 2012;21
(6):621–627.
21.
CoxBMartensENemeryBVangronsveldJNawrotTS. Impact of a stepwise introduction of smoke-free legislation on the rate of preterm births: analysis of routinely collected birth data. BMJ. 2013;346:f441.
22.
BharadwajPJohnsenJLøkenK. Smoking Bans, Maternal Smoking and Birth Outcomes. Bonn, Germany: Institute for the Study of Labor (IZA);2012.
23.
ShahNRBrackenMB. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol. 2000;182
(2):465–472.
24.
EliopoulosCKleinJPhanMK. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA. 1994;271
(8):621–623.
25.
BenowitzNL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18
(2):188–204.
26.
FlorescuAFerrenceREinarsonTSelbyPSoldinOKorenG. Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit. 2009;31
(1):14–30.
27.
PatrickDLCheadleAThompsonDCDiehrPKoepsellTKinneS. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84
(7):1086–1093.
28.
LindqvistRLendahlsLTollbomOAbergHHåkanssonA. Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women. Acta Obstet Gynecol Scand. 2002;81
(3):240–244.
29.
BardyAHSeppäläTLillsundeP. Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br J Obstet Gynaecol. 1993;100
(8):721–726.
30.
ShiptonDTappinDMVadivelooTCrossleyJAAitkenDAChalmersJ. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ. 2009;339:b4347.
31.
Al-DelaimyWK. Hair as a biomarker for exposure to tobacco smoke. Tob Control. 2002;11
(3):176–182.
32.
Al-DelaimyWKMahoneyGNSpeizerFEWillettWC. Toenail nicotine levels as a biomarker of tobacco smoke exposure. Cancer Epidemiol Biomarkers Prev. 2002;11
(11):1400–1404.
33.
ParazziniFDavoliERabaiottiM. Validity of self-reported smoking habits in pregnancy: a saliva cotinine analysis. Acta Obstet Gynecol Scand. 1996;75
(4):352–354.
Secker-WalkerRHVacekPMFlynnBSMeadPB. Smoking in pregnancy, exhaled carbon monoxide, and birth weight. Obstet Gynecol. 1997;89
(5 pt 1):648–653.
36.
GaritiPRosenthalDILindellK. Validating a dipstick method for detecting recent smoking. Cancer Epidemiol Biomarkers Prev. 2002;11
(10 pt 1):1123–1125.
37.
SeidmanDSPazIMerlet-AharoniIVremanHStevensonDKGaleR. Noninvasive validation of tobacco smoke exposure in late pregnancy using end-tidal carbon monoxide measurements. J Perinatol. 1999;19
(5):358–361.
38.
JarvisM. Absorption of nicotine and carbon monoxide from passive smoking under natural conditions of exposure. Thorax. 1983;38
(11):829–833.
39.
DeveciSEDeveciFAçikYOzanAT. The measurement of exhaled carbon monoxide in healthy smokers and non-smokers. Respir Med. 2004;98
(6):551–556.
40.
BaileyBA. Using expired air carbon monoxide to determine smoking status during pregnancy: preliminary identification of an appropriately sensitive and specific cut-point. Addict Behav. 2013;38
(10):2547–2550.
41.
OstreaEMKnappDKRomeroAMontesMOstreaAR. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J Pediatr. 1994;124
(3):471–476.
42.
StevensKRMuñozLR. Cigarette smoking: Evidence to guide measurement. Res Nurs Health. 2004;27
(4):281–292.
43.
GoldsteinHGoldbergIDFrazierTMDavisGE. Cigarette smoking and prematurity. Public Health Rep. 1964;79:553–560.
44.
KramerMS. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ. 1987;65
(5):663–737.
45.
McIntoshID.Smoking and pregnancy: II. Offspring risks. Public Health Rev. 1984;12
(1):29–63.
46.
CnattingiusSGranathFPeterssonGHarlowBL. The influence of gestational age and smoking habits on the risk of subsequent preterm deliveries. N Engl J Med. 1999;341
(13):943–948.
47.
LumleyJOliverSSChamberlainCOakleyL. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004;(4):CD001055.
48.
SalmasiGGradyRJonesJMcDonaldSDGroupKS. Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol Scand. 2010;89
(4):423–441.
49.
KharraziMDeLorenzeGNKaufmanFL. Environmental tobacco smoke and pregnancy outcome. Epidemiology. 2004;15
(6):660–670.
50.
FantuzziGAggazzottiGRighiE. Preterm delivery and exposure to active and passive smoking during pregnancy: a case-control study from Italy. Paediatr Perinat Epidemiol. 2007;21
(3):194–200.
51.
Leonardi-BeeJSmythABrittonJColemanT. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93
(5):F351–F361.
52.
WardCLewisSColemanT. Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birth weight: retrospective study using Millennium Cohort. BMC Public Health. 2007;7:81.
53.
Conde-AgudeloAAlthabeFBelizánJMKafury-GoetaAC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999;181
(4):1026–1035.
54.
HoneinMARasmussenSAReefhuisJ. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology. 2007;18
(2):226–233.
55.
MalikSClevesMAHoneinMA. Maternal smoking and congenital heart defects. Pediatrics. 2008;121
(4):e810–e816.
56.
FlenadyVKoopmansLMiddletonP. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;377
(9774):1331–1340.
57.
PinelesBLParkESametJM. Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol. 2014;179
(7):807–823.
BenowitzNLDempseyDAGoldenbergRL. The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control. 2000;9(suppl 3):III91–III94.
60.
LongoLD. The biological effects of carbon monoxide on the pregnant woman, fetus, and newborn infant. Am J Obstet Gynecol. 1977;129
(1):69–103.
61.
BernardC.[Lessons on the effects of toxic and medicinal substances. 1857]. Cah Anesthesiol. 1991;39
(1):55–60.
62.
LiuSKrewskiDShiYChenYBurnettRT. Association between gaseous ambient air pollutants and adverse pregnancy outcomes in Vancouver, Canada. Environ Health Perspect. 2003;111
(14):1773–1778.
63.
GeorgeLGranathFJohanssonALCnattingiusS. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand. 2006;85
(11):1331–1337.
64.
LuckWNauHHansenRSteldingerR. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther. 1985;8
(6):384–395.
65.
SuzukiKMineiLJJohnsonEE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol. 1980;136
(8):1009–1013.
66.
ResnikRBrinkGWWilkesM. Catecholamine-mediated reduction in uterine blood flow after nicotine infusion in the pregnant ewe. J Clin Invest. 1979;63
(6):1133–1136.
67.
AlbuquerqueCASmithKRJohnsonCChaoRHardingR. Influence of maternal tobacco smoking during pregnancy on uterine, umbilical and fetal cerebral artery blood flows. Early Hum Dev. 2004;80
(1):31–42.
68.
LymperopoulouAHainautFCrimailPDurandJLLocatelliCMaisonC. [Smoking and pregnancy: search for a correlation between cotininemia and Doppler findings]. J Gynecol Obstet Biol Reprod (Paris). 1996;25
(8):824–827.
GuptaPCSubramoneySSreevidyaS. Smokeless tobacco use, birth weight, and gestational age: population based, prospective cohort study of 1217 women in Mumbai, India. BMJ. 2004;328
(7455):1538.
71.
ColemanTCooperSThorntonJG. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med. 2012;366
(9):808–818.
72.
EnglandLJLevineRJMillsJLKlebanoffMAYuKFCnattingiusS. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003;189
(4):939–943.
73.
HolmHJarvisMJRussellMAFeyerabendC. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl). 1992;108
(4):507–511.
74.
AsmussenIKjeldsenK. Intimal ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and nonsmoking mothers. Circ Res. 1975;36
(5):579–589.
75.
NaeyeRL. Effects of maternal cigarette smoking on the fetus and placenta. Br J Obstet Gynaecol. 1978;85
(10):732–737.
76.
HadleyCBMainDMGabbeSG. Risk factors for preterm premature rupture of the fetal membranes. Am J Perinatol. 1990;7
(4):374–379.
77.
Lopez BernalA. Mechanisms of labour--biochemical aspects. BJOG. 2003;110
(suppl 20):39–45.
78.
HapangamaDNeilsonJP. Mifepristone for induction of labour. Cochrane Database Syst Rev. 2009(3):CD002865.
79.
ChallisJRSlobodaDMAlfaidyN. Prostaglandins and mechanisms of preterm birth. Reproduction. 2002;124
(1):1–17.
80.
PiasekMLaskeyJW. Acute cadmium exposure and ovarian steroidogenesis in cycling and pregnant rats. Reprod Toxicol. 1994;8
(6):495–507.
81.
NgSPSteinetzBGLasanoSGZelikoffJT. Hormonal changes accompanying cigarette smoke-induced preterm births in a mouse model. Exp Biol Med (Maywood). 2006;231
(8):1403–1409.
82.
MenonRFortunatoSJMilneGL. Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. Obstet Gynecol. 2011;118
(1):121–134.
83.
MenonRFortunatoSJYuJ. Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta. 2011;32
(4):317–322.
SipowiczMKostrzewskaALaudanskiTAkerlundM. Effects of cadmium on myometrial activity of the nonpregnant human. Interactions with calcium and oxytocin. Acta Obstet Gynecol Scand. 1995;74
(2):93–96.
86.
NishijoMNakagawaHHondaR. Effects of maternal exposure to cadmium on pregnancy outcome and breast milk. Occup Environ Med. 2002;59(6):394–396; discussion 397.
87.
UnterscheiderJO'DonoghueKMaloneFD. Guidelines on Fetal Growth Restriction: A Comparison of Recent National Publications [Published online September 13, 2014]. Am J Perinatol. 2014.
88.
MullenPD. Maternal smoking during pregnancy and evidence-based intervention to promote cessation. Prim Care. 1999;26
(3):577–589.
